Final Report of a Phase II Study of Ibrutinib and Venetoclax in Previously Untreated Waldenström Macroglobulinemia. - Castillo JJ; Branagan AR; Guijosa A; von Keudell G; Ramirez-Gamero A; Chory H; Kobs M; Budano N; Nguyen J; Eurell A; Boyajian C; Meid K; et al. (American journal of hematology, 2026)